Cargando…

Covid-19 in kidney transplant recipients with immunosuppressive therapy

BACKGROUND: Since the outbreak of COVID-19, various treatments have been frequently reported for patients infected with this virus, especially in transplant patients/recipients. Objective: Investigating of kidney transplant patients under immunosuppressive therapy infected with COVID-19 can pave the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheikhalipour, Zahra, Faghihdinevari, Masood, Salehi-Pourmehr, Hanieh, Khameneh, Maryam, Vahedi, Leila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Babol University of Medical Sciences 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272967/ https://www.ncbi.nlm.nih.gov/pubmed/35872680 http://dx.doi.org/10.22088/cjim.12.4.509

Ejemplares similares

Immunosuppression minimization in kidney transplant recipients hospitalized for COVID-19
por: Anton Pampols, Paula, et al.
Publicado: (2021)

188 COVID-19 and Kidney Transplant Recipients: Immunosuppression Management and Outcomes
Publicado: (2021)

Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation
por: Toapanta, Néstor, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)

COVID-19 Hospitalization in Solid Organ Transplant Recipients on Immunosuppressive Therapy
por: Kolla, Epiphane, et al.
Publicado: (2023)

Association of Inflammatory Biomarkers with Immunosuppression Management and Outcomes in Kidney Transplant Recipients with COVID-19
por: AbdulRahim, Nashila, et al.
Publicado: (2021)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
por: Barraclough, Katherine A., et al.
Publicado: (2011)

Cost of Lifetime Immunosuppression Coverage for Kidney Transplant Recipients
por: Page, Timothy F., et al.
Publicado: (2008)

Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient
por: Olaso, Danae, et al.
Publicado: (2021)

Underactive and low compliance bladder: A possible Presentation of COVID-19 vaccination
por: Salehi-Pourmehr, Hanieh, et al.
Publicado: (2022)

Relationship between vitamin D status and immunosuppressive therapy in kidney transplant recipients
por: Filipov, Jean Jeanov, et al.
Publicado: (2015)

Factors Associated With Adherence To Immunosuppressive Therapy And Barriers In Asian Kidney Transplant Recipients
por: Ganjali, Raheleh, et al.
Publicado: (2019)

Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients
por: Merli, Marco, et al.
Publicado: (2021)

The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature
por: Angelico, Roberta, et al.
Publicado: (2021)

Management of Immunosuppression in Kidney Transplant Recipients Who Develop Malignancy
por: Yang, Danwen, et al.
Publicado: (2019)

Factors Associated with Adherence to Immunosuppressive Therapy and Barriers in Asian Kidney Transplant Recipients [Corrigendum]
Publicado: (2020)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation
por: Masset, Christophe, et al.
Publicado: (2022)

Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients
por: Wiedemann, Aurélie, et al.
Publicado: (2022)

Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore
por: Chang, Zi Yun, et al.
Publicado: (2021)

Recipients’ Experiences after Organ Transplantation
por: Sheikhalipour, Z., et al.
Publicado: (2018)

Potential Effects of Immunosuppression on Oxidative Stress and Atherosclerosis in Kidney Transplant Recipients
por: Kwiatkowska, Marlena, et al.
Publicado: (2021)

Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
por: El Sakhawi, Karim, et al.
Publicado: (2020)

Follow-Up Factors Contribute to Immunosuppressant Adherence in Kidney Transplant Recipients
por: Chen, Tingting, et al.
Publicado: (2022)

Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
por: Montero, Camilo, et al.
Publicado: (2022)

Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
por: Montero, Camilo, et al.
Publicado: (2023)

COVID-19 AND IMMUNOSUPPRESSION: A CASE OF COVID-19 IN A RENAL TRANSPLANT RECIPIENT
por: Boparai, Sukhmani, et al.
Publicado: (2020)

Immunosuppression in kidney transplant recipients with COVID-19 infection – where do we stand and where are we heading?
por: Daoud, Ahmed, et al.
Publicado: (2021)

Delayed exacerbation of COVID-19 pneumonia in vaccinated kidney transplant recipients receiving immunosuppressants: a case series
por: Ryu, Tae Hyun, et al.
Publicado: (2023)

In Reply to ‘Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations’
por: Fernandes, Guillaume, et al.
Publicado: (2022)

Efficacy of interventions for adherence to the immunosuppressive therapy in kidney transplant recipients: a meta-analysis and systematic review
por: Zhu, Yichen, et al.
Publicado: (2017)

Transplant of kidneys with small renal cell carcinoma in incompatible, heavily immunosuppressed recipients
por: Ali, AM, et al.
Publicado: (2012)

Prevalence of Non-Adherence to Immunosuppressive Medications in Kidney Transplant Recipients: Barriers and Predictors
por: Taj, Shahd M., et al.
Publicado: (2021)

Immunosuppressant Adherence Factors Differentiating Compliant and Non-Compliant Kidney Transplant Recipients
por: Ostrowski, Piotr, et al.
Publicado: (2023)

A case of varicella zoster infection in kidney transplant recipient using immunosuppressant
por: Adam, Abdirahim Ali Nur, et al.
Publicado: (2023)

Urodynamic Parameters in Spinal Cord Injury-Induced Neurogenic Bladder Rats after Stem Cell Transplantation: A Narrative Review
por: Abolhasanpour, Nasrin, et al.
Publicado: (2020)

Volumetric microsampling for simultaneous remote immunosuppressant and kidney function monitoring in outpatient kidney transplant recipients
por: Zwart, Tom C., et al.
Publicado: (2022)

COVID-19: implications for immunosuppression in kidney disease and transplantation
por: Kronbichler, Andreas, et al.
Publicado: (2020)

COVID-19 in kidney transplantation-implications for immunosuppression and vaccination
por: Kodali, Lavanya, et al.
Publicado: (2022)

Use of Anti-Cytokine Therapy in Kidney Transplant Recipients with COVID-19
por: Bodro, Marta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sbdv9hop70spc46ddtoo94v3bv